Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 1396 AL 1410

Insights into role of microRNA in Alzheimer's disease: From contemporary research to bedside perspective

Bandakinda M, Mishra A.

Int J Biol Macromol. 2023 Dec 31;253(Pt 1):126561. doi: 10.1016/j.ijbiomac.2023.126561. Epub 2023 Sep 1.

Therapeutic targeting of microtubule affinity-regulating kinase 4 in cancer and neurodegenerative diseases

Alam M, Ahmed S, Abid M, Hasan GM, Islam A, Hassan MI.

J Cell Biochem. 2023 Sep;124(9):1223-1240. doi: 10.1002/jcb.30468. Epub 2023 Sep 3.

Berberine derivatives as inhibitors of acetylcholinesterase: A systematic review

Singh YP, Kumar H.

Chem Biol Drug Des. 2023 Dec;102(6):1592-1603. doi: 10.1111/cbdd.14337. Epub 2023 Sep 4.

Lithium: An Old Drug for New Therapeutic Strategy for Alzheimer's Disease and Related Dementia

Shim SS, Berglund K, Yu SP.

Neurodegener Dis. 2023;23(1-2):1-12. doi: 10.1159/000533797. Epub 2023 Sep 4.

Tryptamine: A privileged scaffold for the management of Alzheimer's disease

Singh YP, Kumar H.

Drug Dev Res. 2023 Dec;84(8):1578-1594. doi: 10.1002/ddr.22111. Epub 2023 Sep 7.

Guilingji capsule for Alzheimer's disease: secondary analysis of a randomized non-inferiority controlled trial

Ming Z, Yimiao L, Huichan W, Yu C, Lina MA, Hui P, Hao LI.

J Tradit Chin Med. 2023 Oct;43(5):1019-1025. doi: 10.19852/j.cnki.jtcm.20230404.006.

Pathogenesis of Alzheimer's Disease and Diversity of 1,2,3-Triazole Scaffold in Drug Development: Design Strategies, Structural Insights, and Therapeutic Potential

Singh A, Singh K, Kaur J, Kaur R, Sharma A, Kaur J, Kaur U, Chadha R, Bedi PMS.

ACS Chem Neurosci. 2023 Sep 20;14(18):3291-3317. doi: 10.1021/acschemneuro.3c00393. Epub 2023 Sep 8.

Advances in Alzheimer's Disease-Associated Aβ Therapy Based on Peptide

Wang C, Shao S, Li N, Zhang Z, Zhang H, Liu B.

Int J Mol Sci. 2023 Aug 23;24(17):13110. doi: 10.3390/ijms241713110.

Carbamate as a potential anti-Alzheimer's pharmacophore: A review

Singh YP, Kumar N, Chauhan BS, Garg P.

Drug Dev Res. 2023 Dec;84(8):1624-1651. doi: 10.1002/ddr.22113. Epub 2023 Sep 11.

A Randomized Double-blind Study to Assess the Skin Irritation and Sensitization Potential of a Once-weekly Donepezil Transdermal Delivery System in Healthy Volunteers

Sabbagh MN, Mathew P, Blau A.

Alzheimer Dis Assoc Disord. 2023 Oct-Dec 01;37(4):290-295. doi: 10.1097/WAD.0000000000000578. Epub 2023 Sep 11.

Drug repurposing on Alzheimer's disease through modulation of NRF2 neighborhood

Bourdakou MM, Fernández-Ginés R, Cuadrado A, Spyrou GM.

Redox Biol. 2023 Nov;67:102881. doi: 10.1016/j.redox.2023.102881. Epub 2023 Sep 7.

Placebo analgesia and nocebo hyperalgesia in patients with Alzheimer disease and healthy participants

Matthiesen ST, Sieg M, Andersen SS, Amanzio M, Finnerup NB, Jensen TS, Gottrup H, Vase L.

Pain. 2024 Feb 1;165(2):440-449. doi: 10.1097/j.pain.0000000000003035. Epub 2023 Sep 8.

Translational strategies and systems biology insights for blood-brain barrier opening and delivery in brain tumors and Alzheimer's disease

Song G, Plumlee P, Ahn JY, Wong ST, Zhao H.

Biomed Pharmacother. 2023 Nov;167:115450. doi: 10.1016/j.biopha.2023.115450. Epub 2023 Sep 11.

Orexin Receptor Antagonism: Normalizing Sleep Architecture in Old Age and Disease

Kron JOJ, Keenan RJ, Hoyer D, Jacobson LH.

Annu Rev Pharmacol Toxicol. 2024 Jan 23;64:359-386. doi: 10.1146/annurev-pharmtox-040323-031929. Epub 2023 Sep 14.

The neuroinflammatory astrocytic P2X7 receptor: Alzheimer's disease, ischemic brain injury, and epileptic state

Ahn YH, Tang Y, Illes P.

Expert Opin Ther Targets. 2023 Jul-Dec;27(9):763-778. doi: 10.1080/14728222.2023.2258281. Epub 2023 Sep 15.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias